Does collagen help erectile dysfunction? Many men exploring natural approaches to erectile difficulties encounter collagen supplements marketed for vascular and tissue health. Collagen is the body's most abundant structural protein, essential for blood vessel integrity and connective tissue strength. Whilst collagen forms part of the structural framework within erectile tissue, the question remains whether oral supplementation can meaningfully improve erectile function. This article examines the scientific evidence linking collagen to erectile dysfunction, explores the biological mechanisms involved, and reviews evidence-based treatments recommended by NICE and NHS guidance for men experiencing erectile difficulties.

What Is Collagen and How Does It Work in the Body?

Collagen is the most abundant structural protein in the human body, accounting for approximately 30% of total protein content. It provides essential scaffolding for connective tissues, including skin, bones, tendons, ligaments, and blood vessels. There are at least 28 different types of collagen identified, with types I, II, and III being the most prevalent. In blood vessel walls, types I and III collagen predominate in the structural layers, whilst type IV collagen is found in basement membranes. These collagen molecules form the structural framework that maintains the integrity and elasticity of vascular tissue.

The body naturally produces collagen through a complex biosynthetic process involving fibroblasts and other specialised cells. This process requires adequate levels of vitamin C, proline, glycine, and other cofactors. Collagen molecules are assembled into triple-helix structures that provide tensile strength and elasticity to tissues. Natural collagen production generally declines with age, though the rate and extent vary between tissues and individuals. This decline may be accelerated by factors such as smoking, excessive sun exposure, poor nutrition, and chronic inflammation.

Collagen supplements, available as hydrolysed collagen (collagen peptides) or gelatine, have gained popularity as potential interventions for various health concerns. These supplements are typically derived from bovine, porcine, or marine sources and are broken down into smaller peptides for improved absorption. In the UK, collagen products are classified as food supplements, not licensed medicines, and are not subject to the same regulatory standards as pharmaceutical products. Individuals with allergies should be aware that these supplements may contain bovine or marine allergens. Once ingested, collagen peptides are absorbed in the gastrointestinal tract and distributed throughout the body via the bloodstream. Whilst some evidence suggests these peptides may stimulate the body's own collagen production, the extent to which supplemental collagen directly contributes to tissue repair, and whether it targets specific tissues, remains an area of ongoing research with limited robust clinical evidence.

The Link Between Collagen and Erectile Function

Erectile function depends fundamentally on adequate blood flow to the penis, which is regulated by a complex interplay of vascular, neurological, and hormonal factors. The erectile tissue (corpora cavernosa) contains a network of blood vessels and smooth muscle cells supported by a collagen-rich extracellular matrix. During an erection, increased blood flow fills these vascular spaces whilst the tunica albuginea—a collagen-dense fibrous sheath—compresses venous outflow, maintaining rigidity. The structural integrity of these collagen-containing tissues is therefore theoretically important for normal erectile function.

Some proponents suggest that collagen supplementation might support erectile function by improving vascular health and tissue elasticity. The hypothesis centres on collagen's role in maintaining blood vessel integrity. Additionally, collagen is a component of the smooth muscle extracellular matrix within erectile tissue, and pathological changes in erectile dysfunction often involve fibrosis and remodelling of the corpus cavernosum extracellular matrix rather than simple collagen degradation.

However, there is currently no robust clinical evidence establishing a direct link between oral collagen supplementation and improved erectile function. Whilst collagen is structurally important for vascular and erectile tissues, the assumption that consuming collagen supplements will specifically target penile tissue or reverse erectile dysfunction lacks scientific validation. No large-scale randomised controlled trials have demonstrated that collagen supplementation improves erectile function in men with erectile dysfunction. NICE and NHS guidance do not recommend collagen supplements for the management of erectile dysfunction.

The theoretical mechanisms remain speculative, and patients should be aware that marketing claims often exceed the available evidence. Any potential benefits would likely be indirect—for example, through general improvements in vascular health—rather than a specific effect on erectile tissue. Men experiencing erectile dysfunction should seek evidence-based treatments in line with NICE guidance rather than relying on unproven supplements.

Other Factors That Affect Erectile Function

Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity, typically lasting for at least three months. It is a multifactorial condition influenced by numerous physiological, psychological, and lifestyle factors. Understanding these contributing elements is essential for appropriate management and realistic expectations regarding any intervention, including supplements.

Cardiovascular health is intimately connected to erectile function. Conditions such as hypertension, atherosclerosis, hyperlipidaemia, and diabetes mellitus can damage blood vessels and impair the increased blood flow necessary for erections. In fact, ED often serves as an early warning sign of cardiovascular disease, as the penile arteries are smaller and may show atherosclerotic changes before coronary vessels. Endothelial dysfunction—impaired function of the blood vessel lining—is a common pathway linking cardiovascular risk factors to ED.

Hormonal factors, particularly testosterone levels, play a significant role in sexual desire and erectile function. Hypogonadism (low testosterone) can contribute to reduced libido and erectile difficulties, though it is rarely the sole cause of ED. Other endocrine disorders, including thyroid dysfunction and hyperprolactinaemia, may also affect sexual function.

Neurological conditions such as multiple sclerosis, Parkinson's disease, spinal cord injury, and pelvic surgery can disrupt the nerve signals essential for achieving and maintaining erections. Structural causes, including Peyronie's disease and the effects of pelvic surgery or radiotherapy, may also contribute to erectile difficulties. Psychological factors—including anxiety, depression, stress, and relationship difficulties—are significant contributors to ED, either as primary causes or as consequences that perpetuate the problem.

Lifestyle factors substantially influence erectile function. Smoking damages blood vessels and is strongly associated with ED. Excessive alcohol consumption, obesity, physical inactivity, and poor diet all contribute to both ED and underlying cardiovascular disease. Medications, including certain antihypertensives, antidepressants, and antiandrogens, may cause or worsen erectile difficulties as adverse effects.

Initial assessment in primary care should include a comprehensive evaluation of cardiovascular risk (including QRISK3 score), blood pressure, body mass index (BMI), HbA1c or fasting glucose, lipid profile, and a medication review. Morning total testosterone should be measured, with repeat testing if levels are low. Depending on clinical findings, prolactin and thyroid function tests may be indicated, along with renal and liver function tests. A comprehensive assessment of these factors is essential before attributing ED to any single cause or pursuing specific treatments. Referral to specialist services may be appropriate for suspected endocrine disorders, Peyronie's disease, failure of first-line therapy, neurological signs, or complex psychosexual issues.

Evidence-Based Treatments for Erectile Dysfunction

NICE Clinical Knowledge Summary (CKS) on Erectile Dysfunction recommends a structured approach to managing ED, beginning with thorough assessment and addressing modifiable risk factors before considering pharmacological interventions.

Lifestyle modifications form the foundation of ED management. Evidence supports smoking cessation, reducing alcohol intake, achieving a healthy weight, and increasing physical activity as effective interventions that can improve erectile function whilst simultaneously reducing cardiovascular risk. A Mediterranean-style diet rich in fruits, vegetables, whole grains, and healthy fats has been associated with better erectile function in observational studies.

Phosphodiesterase type 5 (PDE5) inhibitors—including sildenafil, tadalafil, vardenafil, and avanafil—are first-line pharmacological treatments for ED. These medications work by enhancing the effects of nitric oxide, promoting smooth muscle relaxation and increased blood flow to the penis during sexual stimulation. They are effective in approximately 70% of men with ED and are generally well-tolerated. However, they are contraindicated in men taking nitrates (due to the risk of severe hypotension) or riociguat. Caution is required when used with alpha-blockers, and dose adjustments may be necessary in hepatic or renal impairment or in men with baseline hypotension. Common adverse effects include headache, flushing, dyspepsia, and nasal congestion. Urgent medical attention is required if priapism (painful erection lasting more than four hours), sudden visual or hearing loss, or severe chest pain occurs.

For men who do not respond to or cannot tolerate PDE5 inhibitors, second-line treatments include:

• Intracavernosal injections (alprostadil) directly into the penis

• Intraurethral alprostadil (MUSE)

• Vacuum erection devices, which mechanically draw blood into the penis

Third-line and surgical options, such as penile prosthesis implantation, may be considered for men who do not respond to other treatments and should be discussed with urology or andrology specialists.

Testosterone replacement therapy may be appropriate for men with confirmed hypogonadism (low testosterone on repeat testing), though it should only be initiated after proper investigation and under specialist guidance. Psychological interventions, including cognitive behavioural therapy (CBT) and psychosexual counselling, are valuable for men with psychological contributors to ED or for couples experiencing relationship difficulties.

When to seek medical advice: Men experiencing persistent erectile difficulties should consult their GP for proper assessment. This is particularly important as ED may indicate underlying cardiovascular disease requiring investigation. Referral to specialist services may be needed for suspected endocrine disorders, Peyronie's disease, failure of first-line therapy, neurological signs, or complex psychosexual issues.

Patients should be cautious about unregulated supplements claiming to treat ED, as these lack robust evidence, are not subject to the same safety standards as licensed medicines, and may contain undeclared pharmaceutical ingredients. The MHRA regularly issues warnings about such products purchased online. If you experience side effects from any medicine, you can report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions